Search

Your search keyword '"Döhner, Konstanze"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Döhner, Konstanze" Remove constraint Author: "Döhner, Konstanze" Journal leukemia Remove constraint Journal: leukemia
39 results on '"Döhner, Konstanze"'

Search Results

1. Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

2. Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

3. Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients

5. In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts

6. Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)

7. Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients

8. Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

9. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

10. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

11. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

12. Germline variants drive myelodysplastic syndrome in young adults

14. TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition

15. Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study

16. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

18. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)

21. KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis

22. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial

23. Rearrangements involving 11q23.3/KMT2Ain adult AML: mutational landscape and prognostic implications – a HARMONY study

24. Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study

25. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

26. Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo

27. TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition

28. UBTF::ATXN7L3gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

29. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

31. Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)

32. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)

34. Functional characterization of BRCC3mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)

35. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9ain adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)

36. Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

38. KITD816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis

Catalog

Books, media, physical & digital resources